International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Everything Old is New Again

Author(s): Brunner Scott

Issue: Jan/Feb 2022 - Volume 26, Number 1
View All Articles in Issue

Page(s): 30-32

Download in electronic PDF format for $75

Abstract:

Related Keywords: Scott Brunner, CAE, pharmacy regulations, memo of understanding on interstate distribution of compounded products, drug shortages, veterinary compounding, bioidentical hormone therapy, Alliance for Pharmacy Compounding, U.S. Food and Drug Administration, FDA, Center for Veterinary Medicine

Related Categories: HRT, LEGAL, VETERINARY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Everything Old is New Again Brunner Scott	Jan/Feb 2022 Pg. 30-32
Veterinary Transdermal Medications: A to Z Davidson Gigi S	Mar/Apr 2003 Pg. 106-113
The Science Behind Hormone Replacement Therapy, Part 1 Wepfer Scott T	Nov/Dec 2001 Pg. 462-464
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Bioidentical Hormone Replacement Therapy, Part 3, A Review of Wepfer Scott T	Mar/Apr 2002 Pg. 142-146
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Brunner Scott	Jul/Aug 2020 Pg. 296-297
Navigating New Territories in Compounding for Veterinary Medicine Davidson Gigi S	Sep/Oct 2002 Pg. 324-327
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J	Jul/Aug 2004 Pg. 313-319
FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows Brunner Scott	May/Jun 2021 Pg. 206-209
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Kochanowska-Karamyan Anna J	Sep/Oct 2016 Pg. 367-374
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc	Jan/Feb 2014 Pg. 6-12
PreScription: Shortages Continue--Compounding Pharmacies Fill the Gap…Again! Allen Loyd V Jr	May/Jun 2023 Pg. 180
Bioidentical Hormone Replacement Therapy, Part 2, A Review of Wepfer Scott T	Jan/Feb 2002 Pg. 50-54
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Brunner Scott	Jan/Feb 2023 Pg. 22-23
A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot Brunner Scott	Jul/Aug 2021 Pg. 296-297
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1 DeRosa Angela	Nov/Dec 2020 Pg. 466-470
Regulatory and Operational Issues of Founding a Compounding Pharmacy Smith Lisa K	Nov/Dec 2002 Pg. 434-437
Satisfaction of Patients Using Bioidentical Hormones for Hormone Replacement Therapy Santoro Filippo	Sep/Oct 2002 Pg. 378
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Deleruyelle Laura J	Nov/Dec 2016 Pg. 447-454
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr	Jan/Feb 2018 Pg. 7-16
Return to Top